Induction of follistatin precedes gastric transformation in gastrin deficient mice

Biochemical and Biophysical Research Communications

Volumn 376, Issue 3, 2008, Pages 573-577

  Kang, Weiqun ^a   Saqui Salces, Milena ^a   Zavros, Yana ^a   Merchant, Juanita L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Activins; Atrophic gastritis; Follistatin; Gastric cancer; Gastrin; Intestinal metaplasia; Muc6; Mucous neck cell; TFF1

Indexed keywords

ACTIVIN; AMPHIREGULIN; ANGIOGENIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CATHEPSIN E; CHYMASE; CLAUDIN 4; CLUSTERIN; COLLAGENASE 3; CXCL1 CHEMOKINE; CYCLIN D1; EPIREGULIN; FOLLISTATIN; GASTRIN; INHIBIN; JAGGED1; MUCIN 6; STROMELYSIN 2; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATROPHIC GASTRITIS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; MOUSE; MUCOUS CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; FOLLISTATIN; GASTRIC MUCOSA; GASTRINS; HYPERPLASIA; MICE; MICE, KNOCKOUT; MUCINS; MUSCLE PROTEINS; PEPTIDES; PYLORIC ANTRUM; STOMACH NEOPLASMS;

LOTUS; MUS;

EID: 53149151015     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.09.031     Document Type: Article

References (25)

1. Pisani P., Parkin D.M., Bray F., and Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83 (1999) 18-29
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94 (2001) 153-156
3. Correa P., Haenszel W., Cuello C., Tannenbaum S., and Archer M. A model for gastric cancer epidemiology. Lancet 2 (1975) 58-60
4. Lefebvre O., Chenard M.P., Masson R., Linares J., Dierich A., LeMeur M., Wendling C., Tomasetto C., Chambon P., and Rio M.C. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274 (1996) 259-262
5. Xu X., Brodie S.G., Yang X., Im Y.H., Parks W.T., Chen L., Zhou Y.X., Weinstein M., Kim S.J., and Deng C.X. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 19 (2000) 1868-1874
6. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., Lee K.Y., Nomura S., Lee C.W., Han S.B., Kim H.M., Kim W.J., Yamamoto H., Yamashita N., Yano T., Ikeda T., Itohara S., Inazawa J., Abe T., Hagiwara A., Yamagishi H., Ooe A., Kaneda A., Sugimura T., Ushijima T., Bae S.C., and Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109 (2002) 113-124
7. Tebbutt N.C., Giraud A.S., Inglese M., Jenkins B., Waring P., Clay F.J., Malki S., Alderman B.M., Grail D., Hollande F., Heath J.K., and Ernst M. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8 (2002) 1089-1097
8. Judd L.M., Alderman B.M., Howlett M., Shulkes A., Dow C., Moverley J., Grail D., Jenkins B.J., Ernst M., and Giraud A.S. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 126 (2004) 196-207
9. Katz J.P., Perreault N., Goldstein B.G., Actman L., McNally S.R., Silberg D.G., Furth E.E., and Kaestner K.H. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 128 (2005) 935-945
10. Li Q., Karam S.M., Coerver K.A., Matzuk M.M., and Gordon J.I. Stimulation of activin receptor II signaling pathways inhibits differentiation of multiple gastric epithelial lineages. Mol. Endocrinol. 12 (1998) 181-192
11. Stove C., Vanrobaeys F., Devreese B., Van Beeumen J., Mareel M., and Bracke M. Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition. Oncogene 23 (2004) 5330-5339
12. Cipriano S.C., Chen L., Kumar T.R., and Matzuk M.M. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice. Endocrinology 141 (2000) 2319-2327
13. El-Zimaity H.M., Ota H., Graham D.Y., Akamatsu T., and Katsuyama T. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 94 (2002) 1428-1436
14. Zavros Y., Eaton K.A., Kang W., Rathinavelu S., Katukuri V., Kao J.Y., Samuelson L.C., and Merchant J.L. Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene 24 (2005) 2354-2366
15. Friis-Hansen L., Sundler F., Li Y., Gillespie P.J., Saunders T.L., Greenson J.K., Owyang C., Rehfeld J.F., and Samuelson L.C. Impaired gastric acid secretion in gastrin-deficient mice. Am. J. Physiol. 274 (1998) G561-568
16. Lyer P.N., Wilkinson K.D., and Goldstein L.J. An -N-acetyl-d-glycosamine binding lectin from Bandeiraea simplicifolia seeds. Arch. Biochem. Biophys. 177 (1976) 330-333
17. Kang W., Rathinavelu S., Samuelson L.C., and Merchant J.L. Interferon gamma induction of gastric mucous neck cell hypertrophy. Lab. Invest. (2005)
18. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
19. Takaishi S., and Wang T.C. Gene expression profiling in a mouse model of Helicobacter-induced gastric cancer. Cancer Sci. 98 (2007) 284-293
20. Michel U., and Farnworth P. Follistatin steady state messenger ribonucleic acid levels in confluent cultures of a rat renal mesangial cell line are regulated by multiple factors. Endocrinology 130 (1992) 3684-3693
21. van Eyll J.M., Pierreux C.E., Lemaigre F.P., and Rousseau G.G. Shh-dependent differentiation of intestinal tissue from embryonic pancreas by activin A. J. Cell Sci. 117 (2004) 2077-2086
22. Bartholin L., Maguer-Satta V., Hayette S., Martel S., Gadoux M., Corbo L., Magaud J.P., and Rimokh R. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function. Oncogene 21 (2002) 2227-2235
23. Iemura S., Yamamoto T.S., Takagi C., Uchiyama H., Natsume T., Shimasaki S., Sugino H., and Ueno N. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc. Natl. Acad. Sci. USA 95 (1998) 9337-9342
24. Kim S.K., Hebrok M., Li E., Oh S.P., Schrewe H., Harmon E.B., Lee J.S., and Melton D.A. Activin receptor patterning of foregut organogenesis. Genes Dev. 14 (2000) 1866-1871
25. Becker J.C., Hertel M., Markmann A., Shahin M., Werner S., Domschke W., and Pohle T. Dynamics and localization of activin A expression in rat gastric ulcers. Scand. J. Gastroenterol. 38 (2003) 260-267